The effects of vitamin A derivative etretinate on the skin of MRL mice

Abstract

MRL/Mp-lpr/lpr (MRL/lpr) mice are characterized by the disorder of apoptosis due to defects in Fas antigens and autoimmune symptoms including spontaneous lupus erythematosus (LE)-like skin lesions. MRL/Mp- +/+ (MRL/n) mice do not carry the defect of lpr mutation nor do they exhibit skin disorders during the first six months of life. Retinoids are known to inhibit the proliferation of skin fibroblasts, collagen synthesis, modulate immune responses, and apoptosis by Fas ligand upregulation in skin fibroblasts. We examined changes in dermal thickness and appearance of skin disorders in five months old MRL/lpr mice by oral treatment with etretinate, a retinoic acid derivative. Etretinate treated MRL/lpr mice did not have skin lesions or dermatopathological characteristics including an increase in cells infiltrating the dermis. The mean dermal thickness of MRL/lpr and MRL/n mice treated with etretinate decreased significantly and apoptotic cells density in the dermis of MRL/lpr mice with etretinate was significantly higher compared with the control group (P, 0.05) although MRL/lpr mice have a defect within the Fas antigen. We assumed that etretinate reduced dermal thickness, and suppressed the appearance of skin lesions by inducting apoptosis and perhaps regulation of cytokine expression.

Keywords

apoptosis etretinate MRL skin lesion

Get full access to this article

View all access options for this article.

References

Furukawa F , Kanauchi H , Wakita H et al. Spontaneous autoimmune skin lesions of MRL/n mice: autoimmune disease-prone genetic background in relation to Fas-defect MRL/lpr mice . J Invest Dermatol 1996; 107: 95-100 .

Delany AM , Brinckerhoff CE. The synthetic retinoid (4-hydroxyphenyl) retinamide decreases collagen expression in vitro and in the tight-skin mouse . Arthritis Rheum 1993; 36: 983-993 .

Ohta A , Uitto J. Procollagen gene expression by scleroderma fibroblasts in culture. Inhibition of collagen production and reduction of pro alpha 1 (I) and pro alpha 1(I) collagen messenger RNA steady-state levels by retinoids . Arthritis Rheum 1987; 30: 404-411 .

Ikeda T , Uede K , Hashizume H , Furukawa F. The vitamin A derivative etretinate improves skin sclerosis in patients with systemic sclerosis . J Dermatol Sci 2004; 34: 62-66 .

Kinoshita K , Byun-Suk Yoo , Nozaki Y et al. Retinoic acid reduces autoimmune renal injury and increases survival in NZB/WF1 mice . J Immunol 2003; 170: 5793-5798 .

Saito A , Kawanabe T , Weidong H et al. Selective upregulation of fibroblast Fas ligand expression, and prolongation of Fas/Fas ligand-mediated skin allograft survival, by retinoic acid: the skin as a retinoideinducible immune privilege site . J Invest Dermatol 2000; 115: 154-161 .

Yamamoto T , Takahashi Y , Takagawa S , Katayama I , Nishioka K. Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/Wv mice . J Rheumatol 1999; 26: 2628-2634 .

Shigematsu T , Tajima S. Modulation of collagen synthesis and cell proliferation by retinoids in human skin fibroblasts . J Dermatol Sci 1995; 9: 142-145 .

Osada K , Seishima M , Mori S , Seishima M , Takemura M , Noma A. Etretinate administration reduces serum propeptide of type I procollagen level in patients with psoriasis . Br J Dermatol 1994; 131: 655-659 .

10.

Bahmer FA , Zaun H. Isotretinain therapy for progressive systemic sclerosis . Arch Dermatol 1985; 121: 308-308 .

11.

Mizutani H , Yoshida T , Nouchi N , Hamanaka H , Shimizu M. Topical tocoretinate improved hypertropic scar, skin sclerosis in systemic sclerosis and morphea . J Dermatol 1999; 26: 11-17 .

12.

Marcellus DC , Altomonte VL , Farmer ER et al. Etretinate therapy for refractory sclerodermatous chronic graft-versus-host disease . Blood 1999; 93: 66-70 .

13.

Zhang C , Duvic M. Retinoids: therapeutic applications and mechanisms of action in cutaneous T-cell lymphoma . Dermatol Ther 2003; 16: 322-330 .

14.

Orlandi A , Bianchi L , Costanzo A , Campione E , Giusto Spagnoli L , Chimenti S. Evidence of increased apoptosis and reduced proliferation in basal cell carcinomas treated with tazarotene . J Invest Dermatol 2004; 122: 1037-1041 .

15.

Jianguo Wu , Tong Zhou , Jinju Zhang , Jin He , Gause WC , Mountz JD. Correction of accelerated autoimmune disease by early replacement of the mutated lpr gene with the normal Fas apoptosis gene in the T cells of transgenic MRL-lpr/lpr mice . Proc Natl Acad Sci 1994; 91: 2344-2348 .

16.

Chu JL , Drappa J , Parnassa A , Elkon KB. The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon, ETn . J Exp Med 1993; 178: 723-730 .

17.

Margherita TC , Faye EN , Colleen EH. In vitamin A deficiency multiple mechanisms establish a regulatory T helper cell imbalance with excess Th1 and insufficient Th2 function . J Immunol 1994; 152: 1515-1522 .

18.

Nishide T , Yoshimasu T , Ikeda T , Seo N , Ohtani T , Furukawa F. Cytokine profiles of skin lesions in murine lupus models . J Dermatol Sci 2005 (in press).